Sponsored π
winkler | watchlist | Jan. 19, 2021
Portfolio(s): $25k Challenge, Swing Trading Stocks, Day Trading Momo,
Donald Trump became the first US president in history to be impeached twice on Wednesday, when 232 members of the House — including 10 Republicans who bucked party lines — voted in favor of impeaching the president for inciting last week's riot at the US Capitol building. Trump now faces a trial in the Senate, and if convicted, will be barred from ever holding federal office again.
https://www.gzeromedia.com/hard-numbers-some-republican-dissent-italian-mafia-on-trial-rohingya-camp-blaze-joe-the-pigeon-under-attack
Trump Weighs Many Pardons as Presidency Winds Down
President expected to issue as many as 100 pardons and commutations, but leans against some controversial grants at urging of advisers
https://www.wsj.com/articles/trump-weighs-many-pardons-as-presidency-winds-down-11611002181?mod=hp_lead_pos1
Paris and Milan Have That New Car Company Smell
Fiat Chrysler and PSA Group, the maker of Peugeot and Citröen cars, completed their merger on Saturday, creating a brand new car company. The combo was first announced in October 2019, but Covid slowed down the i-dotting and t-crossing.
https://www.morningbrew.com/daily/stories/2021/01/17/fiat-chrysler-psa-group-complete-merger-finally?email=%7B%7Bprofile.email%7D%7D
Timestamps in video description
https://youtu.be/1jQQtkmtSJs
I know we're still having lag. Tomorrow ISP2 will be live so hopefully that will fix it!
---
No. 1: Bakkt SPAC Merger News
No. 2: Lucid Motors SPAC Merger News
https://investorplace.com/2021/01/top-spac-merger-news-this-week-bakkt-lucid-motors-proterra-and-16-more-hot-spacs/
67% 255mc 61f
Jan 15th No company specific news
46% 66mc 88f
No New News..
46% 34mc 23f
45% 250mc 10f
30% 200mc 96f
60% 22mc 11f
60% 260mc 37f
40% 115mc 41f
January 19, 2021 08:03 AM ET (BZ Newswire) -- Biotech
WALTHAM, Mass. and NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV) and Royalty Pharma plc (NASDAQ:RPRX) today announced that Royalty Pharma will acquire Minerva's royalty interest in seltorexant for an upfront payment of $60 million and up to $95 million in additional milestone payments. The additional payments to Minerva will be contingent on the achievement of certain clinical, regulatory and commercialization milestones
Free Gap Scanner + Win 2 Free Stocks π (Each Up To $1600) ππ http://enzlo.com/webull
Best Savings Account Ever! π Win $10 Million - Use Code: WINKLER ππ http://enzlo.com/save
Watchlist ππ https://tradejournal.co/post/monday-pre-market-top-gainers-380/
Are you sure you want to delete "Tuesday Pre-Market Top Gainers $CHNR $NDRA $INUV"?